For: | Quarleri J, Delpino MV. Molecular mechanisms implicated in SARS-CoV-2 liver tropism. World J Gastroenterol 2022; 28(48): 6875-6887 [PMID: 36632318 DOI: 10.3748/wjg.v28.i48.6875] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i48/6875.htm |
Number | Citing Articles |
1 |
Wolfgang Eisenreich, Julian Leberfing, Thomas Rudel, Jürgen Heesemann, Werner Goebel. Interactions of SARS-CoV-2 with Human Target Cells—A Metabolic View. International Journal of Molecular Sciences 2024; 25(18): 9977 doi: 10.3390/ijms25189977
|
2 |
Lung-Yi Mak, Matthew Shing Hin Chung, Xue Li, Francisco Tsz Tsun Lai, Eric Yuk Fai Wan, Celine Sze Ling Chui, Franco Wing Tak Cheng, Esther Wai Yin Chan, Ching Lung Cheung, Ivan Chi Ho Au, Xi Xiong, Wai-Kay Seto, Man-Fung Yuen, Carlos King Ho Wong, Ian Chi Kei Wong. Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease. World Journal of Hepatology 2024; 16(2): 211-228 doi: 10.4254/wjh.v16.i2.211
Abstract(270) |
Core Tip(302) |
Full Article(HTML)(1559)
|
Full Article with Cover (PDF)-6787K(61)
|
Full Article (Word)-1662K(11)
|
Audio-745K(0)
|
Peer-Review Report-180K(29)
|
Answering Reviewers-424K(34)
|
Supplementary Material-127K(37)
|
Full Article (PDF)-6277K(55)
|
Full Article (XML)-185K(33)
|
Times Cited (0)
|
Total Visits (3950)
|
Open
|
3 |
Cyriac Abby Philips, Deepak Madhu, Philip Augustine. Investigating the correlation between COVID-19 and the progression of chronic liver disease. Expert Review of Gastroenterology & Hepatology 2023; 17(6): 603 doi: 10.1080/17474124.2023.2206564
|
4 |
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?. International Journal of Molecular Sciences 2024; 25(4): 2212 doi: 10.3390/ijms25042212
|